IW 378

June 24, 2026 Viktor Zarev 0 min read
  1. Blocked COVID-19 vaccine study published in JAMA journal.
  2. U.S. provides experimental Ebola drug to Congo.
  3. Where did Ebola come from?
  4. Indiana turns to price controls to limit rising healthcare costs. 
  5. Telehealth circumvents federal abortion pill ban. 
  6. Top 10 nonprofit health systems by operating revenue.
  7. Medicare’s WISeR AI preapproval pilot may delay care.
  8. A healthcare attorney’s guide to scaling clinical AI. 
  9. Exposure to daylight linked to lower dementia risk. 
  10. Many candidates in FDA’s ‘breakthrough’ program don’t get approved.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Heart Failure July 4, 2000

How Earlier Hemodynamic Insight May Help Guide Heart Failure Management July 4, 2000

Heart failure continues to place a significant burden on patients and the healthcare system, with nearly 7 million Americans living with heart failure, with prevalence expected to reach nearly 9 million by 2030. Despite advances in guideline-directed medical therapy (GDMT), many patients still face high risks of hospitalization, mortality, and reduced quality of life.

Cardiology Pharmaceuticals July 17, 2026

Can Kerendia Handle the (Blood) Pressure? More Findings from FINEARTS-HF. July 17, 2026

One year after its FDA approval for HF treatment, a new FINEARTS-HF substudy shows Bayer’s Kerendia (finerenone) isn’t just impervious to BP differences, it could actually give a small leg up to patients with hypertension.

Cardiac Imaging July 16, 2026

Zero CAC And The Cost of CCTA-QPA July 16, 2026

The power of a zero CAC score is facing fresh scrutiny after new plaque analysis data presented at SCCT 2026 shows just how much noncalcified plaque confers its own cardiovascular risk, despite the software’s financial barriers.